Showing results (31-40 of 294) with videos related to
Sort By:
Pageof 30
Current Opinion in Otolaryngology & Head and Neck Surgery|February 14, 2012
Oropharyngeal cancer - is it time to change management according to human papilloma virus status?Hisham Mehanna, Oladejo Olaleye, Lisa LicitraSeminars in Oncology|October 14, 2022
Which future for de-intensified treatments in HPV-related oropharyngeal carcinoma?Stefano Cavalieri, Imperia Nuzzolese, Lisa LicitraCurrent Opinion in Oncology|December 7, 2022
Oligometastatic disease from differentiated thyroid cancer: best treatment schemesElena Colombo, Arianna Ottini, Lisa LicitraAdvances in Oto-Rhino-Laryngology|July 31, 2020
The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal CancerLisa Licitra, Carlo Resteghini, Paolo BossiHead & Neck|July 30, 2019
Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tractLaura D Locati, Stefano Cavalieri, Cristiana Bergamini, et al.Thyroid : Official Journal of the American Thyroid Association|September 9, 2016
Quality-of-Life Priorities in Patients with Thyroid Cancer: A Multinational European Organisation for Research and Treatment of Cancer Phase I StudySusanne Singer, Olga Husson, Iwona M Tomaszewska, et al.Oral Oncology|July 4, 2009
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)Laura D Locati, Federica Perrone, Marco Losa, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2016
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to CetuximabPaolo Bossi, Cristiana Bergamini, Marco Siano, et al.Disease Markers|December 21, 2017
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?Paolo Bossi, Marco Siano, Cristiana Bergamini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2006
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinomaLisa Licitra, Federica Perrone, Paolo Bossi, et al.Pageof 30